Diagnosis and management of inflammatory bowel disease in children

Stephanie B Oliveira1, Iona M Monteiro2

  • 1Cincinnati Children's Hospital Medical Center Ringgold standard institution, Cincinnati, OH, USA.

BMJ (Clinical Research Ed.)
|June 2, 2017
PubMed

Insights

Pediatric inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, require careful management to control inflammation and monitor for complications. This review covers the latest evidence on IBD in children and adolescents.

Area of Science:

  • Pediatric gastroenterology and immunology.
  • Chronic inflammatory conditions affecting the gastrointestinal tract.

Background:

  • Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic conditions often diagnosed in childhood.
  • Pediatric IBD significantly impacts a child's growth, development, psychosocial well-being, and overall health.
  • Effective management is crucial for sustained control of intestinal inflammation and monitoring of disease complications and treatment side effects.

Purpose of the Study:

  • To review the current evidence on the pathophysiology, diagnosis, and management of IBD in children and adolescents.
  • To consolidate information from multicenter studies, guidelines, and consensus statements for pediatric IBD care.

Main Methods:

  • Systematic review of existing literature on pediatric inflammatory bowel diseases.
  • Synthesis of data from multicenter studies, clinical guidelines, and expert consensus statements.
  • Focus on pathophysiology, diagnostic approaches, and therapeutic strategies.

Main Results:

  • Evidence for pediatric IBD management is less extensive than for adults, but high-quality multicenter studies are available.
  • Key management involves controlling intestinal inflammation and monitoring for complications and treatment side effects.
  • The review summarizes established and emerging approaches to pediatric IBD.

Conclusions:

  • Optimizing the management of pediatric IBD is essential to mitigate long-term effects on growth and development.
  • A comprehensive understanding of pathophysiology, diagnosis, and evidence-based management is critical for improving outcomes in children and adolescents with IBD.
  • This review provides a consolidated resource for clinicians managing pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
976
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
864
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
780
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
608